Merus NV Schedule 13G passive stakes

Paradigm BioCapital Advisors LP and its affiliates have disclosed a 6.2% beneficial ownership stake in Merus N.V. common shares as of September 30, 2025.

RTW Investments, LP and Roderick Wong have reported a 2.7% beneficial ownership stake in Merus N.V. common shares as of September 30, 2025.

Wellington Management Group LLP and its affiliates have disclosed a 0.61% beneficial ownership stake in Merus N.V. common stock.

FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting a reduced beneficial ownership of 3.7% in Merus N.V. common stock.

Commodore Capital LP and Commodore Capital Master LP have disclosed a 4.7% beneficial ownership stake in Merus N.V., totaling 3,525,000 common shares.

Wellington Management Group LLP, along with its holding companies, reports beneficial ownership of 5.0% of Merus N.V.'s common stock as of June 30, 2025.

Wellington Management Group LLP and its affiliates have filed an amended Schedule 13G, reporting a 6.83% beneficial ownership stake in Merus N.V. as of March 31, 2025.

A group of investment entities and individuals, including Paradigm BioCapital Advisors LP, have disclosed a beneficial ownership of 5.1% in Merus N.V. common shares.

Wellington Management Group LLP and its affiliates have reported a 5.1% beneficial ownership stake in Merus N.V. common stock as of December 31, 2024.